149 related articles for article (PubMed ID: 37314385)
1. Defect of the Endogenous Inhibitory Pain System in Idiopathic Restless Legs Syndrome: A Laser Evoked Potentials Study.
Antelmi E; Squintani GM; Sandri A; Lippolis M; Segatti A; Tinazzi M
Mov Disord; 2023 Sep; 38(9):1688-1696. PubMed ID: 37314385
[TBL] [Abstract][Full Text] [Related]
2. Conditioned pain modulation affects the N2/P2 complex but not the N1 wave: A pilot study with laser-evoked potentials.
Squintani G; Rasera A; Segatti A; Concon E; Bonetti B; Valeriani M; Tinazzi M
Eur J Pain; 2021 Mar; 25(3):550-557. PubMed ID: 33170987
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of the Descending Inhibitory Nociceptive Pathway in Functional Motor Disorders.
Squintani G; Geroin C; Pasquali A; Cavazzana E; Segatti A; Lippolis M; Bonetto C; Antelmi E; Tinazzi M
Mov Disord; 2024 May; 39(5):905-910. PubMed ID: 38469903
[TBL] [Abstract][Full Text] [Related]
4. Functional Evaluation of Small Fiber Pathways in Primary Restless Legs Syndrome: Aδ Pathway Study.
Fila M; Stasiołek M; Markiewicz A; Bogucki A
J Clin Sleep Med; 2017 Dec; 13(12):1455-1462. PubMed ID: 29117885
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Circadian Modification of A
Vollono C; Della Marca G; Testani E; Losurdo A; Virdis D; Ferraro D; Brunetti V; Rossini PM; Le Pera D; Mazza S; Valeriani M
Pain Res Manag; 2019; 2019():5408732. PubMed ID: 31827655
[TBL] [Abstract][Full Text] [Related]
6. Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials.
Zambito-Marsala S; Erro R; Bacchin R; Fornasier A; Fabris F; Lo Cascio C; Ferracci F; Morgante F; Tinazzi M
Parkinsonism Relat Disord; 2017 Jan; 34():43-48. PubMed ID: 27836714
[TBL] [Abstract][Full Text] [Related]
7. A-delta and C-fibres function in primary restless legs syndrome.
Tyvaert L; Laureau E; Hurtevent JP; Hurtevent JF; Derambure P; Monaca C
Neurophysiol Clin; 2009 Dec; 39(6):267-74. PubMed ID: 19962654
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in laser-evoked potentials following trigeminal and hand stimulation in healthy subjects.
de Tommaso M; Ricci K; Montemurno A; Vecchio E
Eur J Pain; 2017 Jul; 21(6):1087-1097. PubMed ID: 28207185
[TBL] [Abstract][Full Text] [Related]
9. Changes in laser-evoked potentials during hypnotic analgesia for chronic pain: a pilot study.
Squintani G; Brugnoli MP; Pasin E; Segatti A; Concon E; Polati E; Bonetti B; Matinella A
Ann Palliat Med; 2018 Jan; 7(1):7-16. PubMed ID: 29156922
[TBL] [Abstract][Full Text] [Related]
10. Laser evoked potential amplitude and laser-pain rating reduction during high-frequency non-noxious somatosensory stimulation.
Valeriani M; Pazzaglia C; Rizzo V; Quartarone A; Vollono C
Clin Neurophysiol; 2018 May; 129(5):920-925. PubMed ID: 29550652
[TBL] [Abstract][Full Text] [Related]
11. Reduced afferent-induced facilitation of primary motor cortex excitability in restless legs syndrome.
Bocquillon P; Charley-Monaca C; Houdayer E; Marques A; Kwiatkowski A; Derambure P; Devanne H
Sleep Med; 2017 Feb; 30():31-35. PubMed ID: 28215259
[TBL] [Abstract][Full Text] [Related]
12. Cortical inhibition of laser pain and laser-evoked potentials by non-nociceptive somatosensory input.
Testani E; Le Pera D; Del Percio C; Miliucci R; Brancucci A; Pazzaglia C; De Armas L; Babiloni C; Rossini PM; Valeriani M
Eur J Neurosci; 2015 Oct; 42(7):2407-14. PubMed ID: 26227011
[TBL] [Abstract][Full Text] [Related]
13. Frontal dysfunction in patients with restless legs syndrome performing a visual oddball task: an event-related potential source imaging study.
Cha KS; Choi JW; Jung KY; Kim KH
Sleep Med; 2017 Aug; 36():48-54. PubMed ID: 28735921
[TBL] [Abstract][Full Text] [Related]
14. Laser-Evoked Potentials to Pudendal Stimulation in Healthy Subjects: A Pilot Study.
Frasson E; Tozzi MC; Bordignon M; Motti L; Ferrari F; Torre G; Graziottin A; Monaco S; Bertolasi L
J Clin Neurophysiol; 2021 Jul; 38(4):317-322. PubMed ID: 32217884
[TBL] [Abstract][Full Text] [Related]
15. Impaired Sensorimotor Integration in Restless Legs Syndrome.
Lin Y; Wang Y; Zhan S; Ding Y; Hou Y; Wang L; Wang Y
Front Neurol; 2018; 9():568. PubMed ID: 30050496
[No Abstract] [Full Text] [Related]
16. The Analgesic Effect of Oxytocin in Humans: A Double-Blind, Placebo-Controlled Cross-Over Study Using Laser-Evoked Potentials.
Paloyelis Y; Krahé C; Maltezos S; Williams SC; Howard MA; Fotopoulou A
J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26660859
[TBL] [Abstract][Full Text] [Related]
17. Sensory symptoms in restless legs syndrome: the enigma of pain.
Winkelman JW; Gagnon A; Clair AG
Sleep Med; 2013 Oct; 14(10):934-42. PubMed ID: 23948222
[TBL] [Abstract][Full Text] [Related]
18. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
[TBL] [Abstract][Full Text] [Related]
19. The effect of heterotopic noxious conditioning stimulation on Aδ-, C- and Aβ-fibre brain responses in humans.
Torta DM; Churyukanov MV; Plaghki L; Mouraux A
Eur J Neurosci; 2015 Nov; 42(9):2707-15. PubMed ID: 26369522
[TBL] [Abstract][Full Text] [Related]
20. Effects of aging on laser evoked potentials.
Creac'H C; Bertholon A; Convers P; Garcia-Larrea L; Peyron R
Muscle Nerve; 2015 May; 51(5):736-42. PubMed ID: 25212497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
